IN-VITRO DEVICE MONITORING DURING MINIMALLY INVASIVE ABLATION THERAPY

• US 20100331833A1
• Filed: 06/26/2009
• Published: 12/30/2010
• Est. Priority Date: 06/26/2009
• Status: Abandoned Application

• Current Assignee: Siemens AG
• Original Assignee: Siemens AG
• Inventors: Maschke, Michael, Schmidt, Sebastian, Hiltawsky, Karsten, Zahlmann, Gudrun
• Application Number:
  US12/492,315
• Publication Number:
  US 20100331833A1
• Time in Patent Office: Days
• US Class Current: 606/20
• CPC Class Codes: A61B 18/02 by cooling, e.g. cryogenic techniques devices for cooling specific reflex points of the body within cell-life limits A61H39/06
• CPC Class Codes: A61B 18/14 Probes or electrodes therefor
• CPC Class Codes: A61B 18/20 using laser
• CPC Class Codes: A61B 2090/376 using X-rays, e.g. fluoroscopy
• CPC Class Codes: A61B 34/20 Surgical navigation systems; Devices for tracking or guiding surgical instruments, e.g. for frameless stereotaxis
• CPC Class Codes: G01N 33/50 Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing measuring or testing processes involving enzymes or microorganisms, compositions or test papers therefor; processes for forming such compositions, condition responsive control in microbiological or enzymological processes C12Q
• CPC Class Codes: G16H 10/40 for data related to laboratory analysis, e.g. patient specimen analysis
• CPC Class Codes: G16H 20/40 relating to mechanical, radiation or invasive therapies, e.g. surgery, laser therapy, dialysis or acupuncture

Abstract

A method and apparatus for monitoring and controlling interventional therapy is described, where the interventional therapy results in the destruction of tissue and the release of chemical markers. When interventional therapy results in destruction of a patient tissue, such as cancerous tissue, a variety of chemical markers may be released into the bloodstream. An in-vitro diagnostic (IVD) device may be used to measure the concentration of an analyte representing a marker and compare the measured concentration with a predetermined set point so as to monitor or control the procedure. The blood for the analysis may be obtained either inter-procedurally or intra-procedurally depending on the promptness of the effect being measured and the speed of measurement.

Claims

1. A method of monitoring or controlling an interventional procedure, comprising the acts of:

establishing a procedure-specific analyte and a set-point value thereof;

obtaining a sample of a bodily fluid;

performing the interventional procedure

determining a value of the analyte in the bodily fluid; and

comparing the analyte value with the set-point value.

2. The method of claim 1, wherein the interventional procedure is an ablation procedure.

3. The method of claim 1, wherein the procedure-specific analyte is a biomarker.

4. The method of claim 1, wherein the value of the analyte is determined by an in-vitro diagnostic device (IVD).

5. The method of claim 4, wherein the IVD uses a microfluidic device.

6. The method of claim 4, wherein the IVD uses a lab-on-a-chip.

7. The method of claim 4, wherein the IVD uses a DNA micro-array.

8. The method of claim 1, wherein the step of comparing the analyte value results in determining that the analyte value is less than the set-point value, the step of performing the interventional procedure is continued.

9. The method of claim 8, further comprising:

performing the interventional procedure in fractions, and the act of obtaining a sample of bodily fluid is performed after the act of performing each fraction.

10. The method of claim 8 wherein act of performing obtaining the sample of bodily fluid is performed at intervals during the interventional procedure.

11. The method of claim 1, further comprising:

performing the interventional procedure using a device having a controllable intensity.

12. The method of claim 11, further comprising controlling an initial intensity of the device to be below a predetermined safety limit.

13. The method of claim 12, wherein when the measured analyte is less than the set-point value, the intensity is increased, while controlling the intensity to remain lower than the safety limit.

14. The method of claim 12, wherein when the measured analyte is greater than the set point value, controlling the intensity to be decreased.

15. The method of claim 1, wherein the set-point value is proportional to a mass of tissue to be destroyed by the procedure, the method further comprising:

comparing the set point value with the cumulative value of the analyte from a start of the interventional procedure, and discontinuing the interventional procedure when the cumulative value is equal to the set point.

16. The method of claim 1, further comprising determining a minimum analyte value as a set point, the set point representing a minimum rate of tissue destruction, and discontinuing the treatment when the analyte value falls below the set point for a specific intensity.

17. The method of claim 1, wherein the set point comprises a first set point and a second set point, the first set point representing a value of a first analyte for which a criteria of destroying selected tissue is met, and a second set point representing a value of a second analyte for which a criteria of not destroying healthy tissue is met, and continuing the procedure when both the condition of destroying selected tissue and not destroying healthy tissue is met.

18. The method of claim 1, wherein the bodily fluid is blood.

19. The method of claim 18, wherein the blood is drawn from a vein proximal to the tissue being treated.

20. A system for interventional treatment comprising:

an interventional apparatus capable of delivering or removing localized energy to a location in a patient body;

an in-vitro diagnostic (IVD) device;

wherein a bodily fluid is analyzed by the IVD device to determine a value of an analyte, and the value of the analyte is compared with a pre-determined value to control a value of the localized energy.

21. The system of claim 20, wherein the interventional apparatus is an ablation tool.

22. The system of claim 21, where the ablation tool is one of a laser, a radio frequency heater, a high-intensity ultrasound device, or a cryogenic cooler.

23. The system of claim 20, wherein the analyte is a biomarker.

24. The system of claim 20, where the bodily fluid is blood.

25. A computer program product, stored on a machine readable medium, comprising:

instructions for configuring a computer to;

accept a measured value of an analyte from an in-vitro diagnostic (IVD) device;

compare the measured value of the analyte with a stored value and control the energy delivered or removed from a patient by an interventional device based on a relation between the measured value and the stored value.

26. The computer program product of claim 25, wherein the stored value represents pre-computed value determined as a set-point

27. The computer program product of claim 26, wherein the set-point is one of:

a rate of destruction of targeted tissue, a total amount of targeted tissue destroyed, a minimum rate of destruction of targeted tissue per unit of energy, or a maximum rate of destruction of non-targeted tissue.